Shortage Notice: Minims Phenylephrine 2.5% & 10% w/v eye drops

Shortage Notice: Minims Phenylephrine 2.5% & 10% w/v eye drops

November 15, 2019

SDA/2019/008

Issued: 14 November 2019

The Department of Health and Social Care (DHSC) have advised that Minims phenylephrine 2.5% and 10% w/v eye drops will be out of stock from the end of November 2019 until early January 2020. Bausch and Lomb are experiencing supply issues across their phenylephrine Minims range.

Action required: 

Specialist importer companies have confirmed that they can source unlicensed supplies of preservative free phenylephrine eye drops in both strengths, but the quantities are limited. There are enough unlicensed supplies of phenylephrine 10% w/v eye drops available to meet normal UK demand until end of January 2020. However, there is insufficient unlicensed supplies of phenylephrine 2.5% w/v eye drops available to meet normal UK demand.

Please see the alert for further information.

Pharmacy team are reminded that where a prescriber wishes you to dispense an import, prescriptions must be annotated ‘specials/unlicensed import’.

A prescription calling for the unlicensed product should be endorsed as follows:

  • Quantity dispensed
  • Pack size
  • Price per unit less any discount/rebate
  • Manufacturer/importer MHRA license number
  • Batch number
  • Specials procurement fee endorsement of ‘SP’

As a reminder, all prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission.

See our factsheet for further guidance on endorsing unlicensed specials and imports.

For more information on medicines shortages, click here.

To report a medicine shortage, click here.

If you have any queries, please contact supplyresiliencemd@dhsc.gov.uk

 

 

 



Posted in: ,


More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...